Komori
Japan Tobacco (2914) · InitiativeAdvanced

Further Strengthening Cost Competitiveness

First written in FY2016. 4 of 5 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2017.

5entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017-Q1 – FY20172017: 420172018: 12018
Same theme, other companies
Earnings Stabilization Through Cross-Functional Business Structural ReformA theme 139 companies write about · 2 as a headwind · 139 as a tailwind

71 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 139 companies compared. The sentences above are computed from all 139.
Full recordFilings, disclosures and news, newest first
  1. FY2017AdvancedAnnual report

    「Adjusted operating profit on a dollar basis, including foreign exchange effects, increased 1.4% year on year, as cost reductions from optimizing manufacturing locations and other measures were realized despite the recognition of a one-off loss associated with a UK business partner applying for proceedings under the UK insolvency law and adverse foreign exchange effects on local currencies such as the pound. On a constant-currency basis, adjusted operating profit on a dollar basis increased 4.0%.」

    Cost reductions from optimizing manufacturing locations and other measures were reflected in the full-year results, resulting in a 1.4% increase in adjusted operating profit on a dollar basis in the international tobacco business and a 4.0% increase on a constant-currency basis.
  2. FY2017-Q3AdvancedAnnual report

    「Adjusted operating profit on a dollar basis, including foreign exchange effects, increased 4.6% year on year, as cost reductions from optimizing manufacturing locations and other measures were realized despite adverse foreign exchange effects on local currencies such as the pound. On a constant-currency basis, adjusted operating profit on a dollar basis increased 9.2%.」

    The international tobacco business realized cost reductions from optimizing manufacturing locations and other measures, resulting in a 4.6% year-on-year increase in adjusted operating profit on a dollar basis and a 9.2% increase on a constant-currency basis.
  3. FY2017-Q2AdvancedAnnual report

    「Adjusted operating profit on a dollar basis, including foreign exchange effects, increased 0.5% year on year, as cost reductions from optimizing manufacturing locations and other measures were realized despite adverse foreign exchange effects on local currencies such as the pound. On a constant-currency basis, adjusted operating profit on a dollar basis increased 9.1% year on year.」

    The international tobacco business realized cost reductions from optimizing manufacturing locations and other measures, resulting in a 0.5% year-on-year increase in adjusted operating profit on a dollar basis and a 9.1% increase on a constant-currency basis.
  4. FY2017-Q1AdvancedAnnual report

    「Adjusted operating profit on a dollar basis, including foreign exchange effects, decreased 6.1% year on year. This reflected increased investment in emerging markets and Emerging Products, as well as adverse foreign exchange effects on local currencies such as the pound, despite the realization of cost reductions from optimizing manufacturing locations and other measures.」

    The Group states that cost reductions from optimizing manufacturing locations and other measures were realized in the international tobacco business, demonstrating the effects of initiatives to strengthen cost competitiveness.
  5. FY2016First statedAnnual report

    「With regard to further strengthening cost competitiveness, the Group will optimize both business and corporate costs, establish a swift and efficient operating structure while maintaining and improving quality, and seek to improve profit margins and strengthen its ability to generate cash flow.」

    The Group presents the optimization of business and corporate costs, an efficient operating structure, and improvements in profit margins and cash flow generation as an integrated basic strategy.
Moved together

"R&D for next-generation strategic products and the profit contribution of the pharmaceutical business" moved the same way as this thread, in the same document, in 4 of its 5 moves.

433222★123456
  1. ★This thread
  2. 1R&D for next-generation strategic products and the profit contribution of the pharmaceutical business4×
  3. 2Capital Allocation Including Dividends and Share Repurchases3×
  4. 3Strengthening Brand Equity Centered on GFB3×
  5. 4Expanding the Brand Portfolio and Strengthening Competitiveness Through Acquisitions2×
  6. 5Stable Operating Cash Flow and Diverse Funding Sources2×
  7. 6Strengthening the Business Base Through Geographic Expansion into Emerging Markets2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Japan Tobacco's next results are scheduled for 2026-10-29. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.